39 research outputs found

    23 - An Introduction to Systematic Reviews: Effects of Green Tea Polyphenols on Diet-Induced Obesity and Intestinal Microbiota

    Get PDF
    The obesity epidemic is a major public health concern worldwide. In the U.S, nearly 4 out of 10 adults and 2 out of 10 children are obese. Diet supplements are widely used as one possible countermeasure. Epigallocatechin gallate (EGCG), one of the major polyphenols present in green tea, can be found in supplement form. Indeed, green tea polyphenols, such as EGCG, inhibit diet-induced obesity and have the potential to alter intestinal microbiota composition. Our research question is: Do green tea polyphenols reduce diet-induced obesity by modulating the intestinal microbiota? To answer this question, we are carrying out a systematic review—a formal research study that follows a clear, predefined structure to find, assess, and analyze studies that have all tried to answer a similar question. Here, we show its completed first step: the search for evidence, which is based on a strategy able to find all relevant studies. We searched four databases using a string of keywords organized in Boolean logic, and identified a total of 67 studies, including duplicates. We excluded all studies that did not address all three facets included in our research question (green tea polyphenols, obesity, and microbiota) and all review articles. After the exclusion process, 14 articles were selected as the most relevant to address our research question. The next step will be to analyze their findings while considering any biases or discrepancies which might be present

    Local characterization of ferromagnetic properties in ferromagnet/superconductor bilayer by Point Contact Andreev Reflection Spectroscopy

    Full text link
    We realized point contact spectroscopy experiment on ferromagnet/superconductor bilayers. Differential conductance curves show several features that we explained within Bogoliubov-de Gennes formalism considering the presence of two interfaces in the normal-metal-tip/ferromagnet/superconductor device. We demonstrate that such configuration is suitable as local probe of the spin polarization and thickness of ferromagnetic layer, directly on bilayer areas. This is due to the high sensitivity of the Andreev surface states to the physical properties of the ferromagnetic interlayer

    A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas

    Get PDF
    Background: Prolactinoma, the most common pituitary adenoma, is usually treated with dopamine agonist (DA) therapy like cabergoline. Surgery is second-line therapy, and radiotherapy is used if surgical treatment fails or in relapsing macroprolactinoma. Objective: This study aimed to provide economic evidence for the management of prolactinoma in Italy, using a cost-of-illness and cost-utility analysis that considered various treatment options, including cabergoline, bromocriptine, temozolomide, radiation therapy, and surgical strategies. Methods: The researchers conducted a systematic literature review for each research question on scientific data- bases and surveyed a panel of experts for each therapeutic procedure's specific drivers that contributed to its total cost. Results: The average cost of the first year of treatment was euro2,558.91 and euro3,287.40 for subjects with micro- prolactinoma and macroprolactinoma, respectively. Follow-up costs from the second to the fifth year after ini- tial treatment were euro798.13 and euro1,084.59 per year in both groups. Cabergoline had an adequate cost-utility profile, with an incremental cost-effectiveness ratio (ICER) of euro3,201.15 compared to bromocriptine, based on a willingness-to-pay of euro40,000 per quality-adjusted life year (QALY) in the reference economy. Endoscopic sur- gery was more cost-effective than cabergoline, with an ICER of euro44,846.64. Considering a willingness-to-pay of euro40,000/QALY, the baseline findings show cabergoline to have high cost utility and endoscopic surgery just a tad above that. Conclusions: Due to the favorable cost-utility profile and safety of surgical treatment, pituitary surgery should be considered more frequently as the initial therapeutic approach. This management choice could lead to better outcomes and an appropriate allocation of healthcare resources

    Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models

    Get PDF
    Antibody drug conjugates represent an important class of anti-cancer drugs in both solid tumors and hematological cancers. Here, we report preclinical data on the anti-tumor activity of the first-in-class antibody drug conjugate MEN1309/OBT076 targeting CD205. The study included preclinical in vitro activity screening on a large panel of cell lines, both as single agent and in combination and validation experiments on in vivo models. CD205 was first shown frequently expressed in lymphomas, leukemias and multiple myeloma by immunohistochemistry on tissue microarrays. Anti-tumor activity of MEN1309/OBT076 as single agent was then shown across 42 B-cell lymphoma cell lines with a median IC50 of 200 pM and induction of apoptosis in 25/42 (59.5%) of the cases. The activity appeared highly correlated with its target expression. After in vivo validation as the single agent, the antibody drug conjugate synergized with the BCL2 inhibitor venetoclax, and the anti-CD20 monoclonal antibody rituximab. The first-in-class antibody drug targeting CD205, MEN1309/OBT076, demonstrated strong pre-clinical anti-tumor activity in lymphoma, warranting further investigations as a single agent and in combination

    Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

    Get PDF
    Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

    Attivita motoria adattata in eta giovanile: la sindrome di Wolf-Hirschhorn.

    No full text
    Il presente lavoro propone un protocollo di attività motoria adattata per un soggetto diversamente abile in età giovanile affetto dalla sindrome di Wolf-Hirschhorn. Nel primo capitolo viene spiegata l'origine dell'attività fisica adattata, la sua evoluzione nel tempo e gli strumenti di classificazione della disabilità. Il secondo capitolo descrive brevemente le caratteritiche dell'età evolutiva prestando particolare attenzione alla fase dell'adolescenza. il terzo capitolo descrive la sindrome di Wolf-Hirschhorn nei suoi aspetti clinici, definendone il profilo citogenetico.nel quarto capitolo verrà data una descrizione del profilo neuropsicologico della WHS, necessaria per poter individuare gli aspetti metodologici ed operativi nell'elaborazione di un programma riabilitativo e/o di mantenimento. il quinto capitolo descrive l'esperienza diretta con una giovane ragazza affetta dalla sindrome di Wolf-Hirschhorn. Partendo dall'esame morfologico-funzionale è stato elaborato un protocollo di attività motoria adattata. la tesi siconclude con la discussione dei risultati raggiunti
    corecore